These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30080881)

  • 1. Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids.
    Michalak EM; Milevskiy MJG; Joyce RM; Dekkers JF; Jamieson PR; Pal B; Dawson CA; Hu Y; Orkin SH; Alexander WS; Lindeman GJ; Smyth GK; Visvader JE
    PLoS Biol; 2018 Aug; 16(8):e2004986. PubMed ID: 30080881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMITATION SWITCH is required for normal chromatin structure and gene repression in PRC2 target domains.
    Kamei M; Ameri AJ; Ferraro AR; Bar-Peled Y; Zhao F; Ethridge CL; Lail K; Amirebrahimi M; Lipzen A; Ng V; Grigoriev IV; Schmitz RJ; Liu Y; Lewis ZA
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.
    Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP
    Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.
    Streubel G; Watson A; Jammula SG; Scelfo A; Fitzpatrick DJ; Oliviero G; McCole R; Conway E; Glancy E; Negri GL; Dillon E; Wynne K; Pasini D; Krogan NJ; Bracken AP; Cagney G
    Mol Cell; 2018 Apr; 70(2):371-379.e5. PubMed ID: 29606589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
    Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
    Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capturing the Onset of PRC2-Mediated Repressive Domain Formation.
    Oksuz O; Narendra V; Lee CH; Descostes N; LeRoy G; Raviram R; Blumenberg L; Karch K; Rocha PP; Garcia BA; Skok JA; Reinberg D
    Mol Cell; 2018 Jun; 70(6):1149-1162.e5. PubMed ID: 29932905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.
    Sanulli S; Justin N; Teissandier A; Ancelin K; Portoso M; Caron M; Michaud A; Lombard B; da Rocha ST; Offer J; Loew D; Servant N; Wassef M; Burlina F; Gamblin SJ; Heard E; Margueron R
    Mol Cell; 2015 Mar; 57(5):769-783. PubMed ID: 25620564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycomb Repressive Complex 2 in Oncology.
    Guo Y; Yu Y; Wang GG
    Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
    Lavarone E; Barbieri CM; Pasini D
    Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2.
    Lee CH; Holder M; Grau D; Saldaña-Meyer R; Yu JR; Ganai RA; Zhang J; Wang M; LeRoy G; Dobenecker MW; Reinberg D; Armache KJ
    Mol Cell; 2018 May; 70(3):435-448.e5. PubMed ID: 29681498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2.
    Pal B; Bouras T; Shi W; Vaillant F; Sheridan JM; Fu N; Breslin K; Jiang K; Ritchie ME; Young M; Lindeman GJ; Smyth GK; Visvader JE
    Cell Rep; 2013 Feb; 3(2):411-26. PubMed ID: 23375371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation.
    Kraft K; Yost KE; Murphy SE; Magg A; Long Y; Corces MR; Granja JM; Wittler L; Mundlos S; Cech TR; Boettiger AN; Chang HY
    Proc Natl Acad Sci U S A; 2022 May; 119(22):e2201883119. PubMed ID: 35617427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of EZH1 and EZH2 in development and cancer.
    Lee SH; Li Y; Kim H; Eum S; Park K; Lee CH
    BMB Rep; 2022 Dec; 55(12):595-601. PubMed ID: 36476271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not just a writer: PRC2 as a chromatin reader.
    Uckelmann M; Davidovich C
    Biochem Soc Trans; 2021 Jun; 49(3):1159-1170. PubMed ID: 34060617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycomb repressive complex 2 and H3K27me3 cooperate with H3K9 methylation to maintain heterochromatin protein 1α at chromatin.
    Boros J; Arnoult N; Stroobant V; Collet JF; Decottignies A
    Mol Cell Biol; 2014 Oct; 34(19):3662-74. PubMed ID: 25047840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
    Mu W; Starmer J; Yee D; Magnuson T
    Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing decouples local from global PRC2 activity.
    Arecco N; Mocavini I; Blanco E; Ballaré C; Libman E; Bonnal S; Irimia M; Di Croce L
    Mol Cell; 2024 Mar; 84(6):1049-1061.e8. PubMed ID: 38452766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for transmission of the H3K27me3 epigenetic mark.
    Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
    Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for PRC2 engagement with chromatin.
    Glancy E; Ciferri C; Bracken AP
    Curr Opin Struct Biol; 2021 Apr; 67():135-144. PubMed ID: 33232890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone methylation by PRC2 is inhibited by active chromatin marks.
    Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
    Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.